Denis Nash has been awarded the prestigious Fulbright-Tocqueville Distinguished Chair Award during his upcoming sabbatical. The award, one of the most selective in the Fulbright Scholars program, aims to “create, […]
A team co-led by CUNY SPH Distinguished Professor Christian Grov was awarded a two-year $420,000 grant from the National Institute on Drug Abuse (NIDA) to identify preferences for the delivery of long-acting […]
Researchers from the Institute for Implementation Science in Population Health (CUNY ISPH) at CUNY SPH have successfully renewed an NIH R01 grant for $2.5 million, funding research into the relationship […]
Dr. Levi Waldron, Investigator at the CUNY Institute for Implementation Science in Population Health (ISPH) at the Graduate School of Public Health and Health Policy (CUNY SPH), has been awarded […]
The Informatics Technology for Cancer Research (ITCR) program of the NIH National Cancer Institute awarded Investigators at the CUNY Institute for Implementation Science in Population Health (ISPH) a competitive renewal […]
The American Transformative HIV Study (AMETHST) cohort— co-led by ISPH Investigator Dr. Christian Grov and Dr. Adam Carrico of Florida International University—is wrapping up Year 2! In 2022-2023, Dr. Grov […]
ISPH Investigator Philip Kreniske has received $2.9M from NIMH for his study, ICARE (Improving understanding of Capacity to consent to sensitive biomedical Research among adolescents in Rakai Uganda). In partnership with the Rakai Health […]
The City University of New York (CUNY) Institute for Implementation Science in Population Health (ISPH) and the CUNY Graduate School of Public Health and Health Policy (CUNY SPH), in collaboration with Pfizer, are initiating […]
In the U.S., sexual and gender minority populations are disproportionately affected by HIV. Pre-exposure prophylaxis (PrEP) is a key prevention method, but its effectiveness relies on consistent usage. While a […]
A study by CUNY ISPH Investigator Levi Waldron and colleagues investigated how gut microbiome changes in patients receiving immune therapy for advanced melanoma affect their treatment outcomes. By analyzing the gut bacteria […]